''REMAIN HUNGRY FOR GROWTH AND CHALLENGE THE STATUS QUO''
Best Advice I Ever Got
Firms Must Test Cyber Resilience Plans, Policies
Fear, uncertainity and rapid busniess shifts have created the perfect storm for cybercriminals to capitalise on
Recessions Are The Mothers of IT Invention
As it is transitioning from a support function to becoming the business itself, great fortunes will be made and lost in the next half decade
Industry: Brewing Trouble
India’s nascent microbrewery industry is facing the double whammy of lockdown blues and high taxation
WILL ROPE IN PRIVATE HOSPITALS IF CASES SURGE”
The Ayushman Bharat Pradhan Mantri Jan Arogya Yojana (AB-PMJAY), the flagship health insurance scheme of the Central government, has just reached the one-crore treatment landmark. The total cost has been around ₹14,000 crore so far. Launched 20 months ago, the scheme – a partnership between Centre and states – provides ₹5 lakh a year health cover to 10.74 crore poor families. Dr Indu Bhushan, CEO, National Health Authority, which implements the AB-PMJAY, talks to Joe C. Mathew about how the AB-PMJAY cover can help the poor fight the Covid-19 emergency. Edited excerpts.
Sky is Limited
Airlines have taken to the skies after two months. But their pain is far from over
Management: Spacing it Out
WITH SOCIAL DISTANCING NORMS IN PLACE, OPEN OFFICE DESIGNS ARE BEING TURNED UPSIDE DOWN
Corporate: Pangs of High Leverage
With the post-lockdown economy still to pick up, highly leveraged companies are looking at ways to reduce debt
A Lot of Bull
Why the sharp recovery and sustained run in stock markets is built on weak fundamentals. Despite the fall, they are trading at double the valuation of the 2008 Lehman crash
Bond Fund With a Difference
BHARAT BOND ETFS ARE AN OPPORTUNITY TO INVEST IN AAA-RATED PSUS AT LOW COST WITH PREDICTABLE RETURNS AND EQUITIES-LIKE LIQUIDITY
The Curious Case of WHO Funding
US President Donald Trump’s announcement to end support for WHO is a reminder for the much-needed reforms in the agency’s financial structure
Managing The Debt Challenge
Rising debt of Centre and states is set to weaken the country's credit profile. What is the way out?
Technology: Tech-Tonic Shift In Hotels
From smartphones doubling up as room keys to real-time data access for staff to new solutions for cleaner air, technology is transforming the hospitality sector
GROWTH SHOULD PICK UP FROM SECOND HALF OF THE FISCAL
India's economy is expected to shrink in FY21. The government has come out with several reforms of late to make the country a global manufacturing hub and push jobs and growth. Niti Aayog CEO Amitabh Kant, while speaking with Business Today’s Nirbhay Kumar, says that foreign companies are strongly considering the possibility of shifting manufacturing to India given its low costs and a huge market. Kant talks about plans to attract foreign investment, boost local demand and reforms kick-started by the government. Edited excerpts:
“The ISA wants a solarised hospital in every district”
The International Solar Alliance (ISA) took shape at the United Nations Climate Change Conference (COP 21) held in Paris in 2015. Its formation was spearheaded by Prime Minister Narendra Modi. Headquartered in India, ISA has 86 signatories, 67 member countries, and 48 partners. It plans to facilitate more than $1,000-billion investment in solar energy by 2030. Upendra Tripathy, Founding Director General, ISA, and former secretary, Ministry of New and Renewable Energy, spoke to P.B. Jayakumar about the alliance’s future plans. Edited excerpts.
In a world that has changed, businesses are looking at new organisational structures
Best Advice I Ever Got
“WE NEED TO COUNT UPON THE ‘COLLECTIVE WISDOM’ OF OUR TEAM” MANISH SHARMA, PRESIDENT AND CEO, PANASONIC INDIA & SOUTH ASIA
How Mukesh Ambani is pivoting RIL from a petroleum company to a technology corporation
The Solar Mirage
India’s solar capacity addition is slowing as viability of projects and host of other issues trouble developers
THE INDIAN HAND
Whether India develops a Covid-19 vaccine/drug or not, Indian companies will be preferred partners for global pharma to make and distribute the life-saving drug globally
With the insolvency and bankruptcy law suspended, the ecosystem of professionals around it faces disruption and uncertainty
Ticking Time Bomb
Up to ₹40 lakh crore worth of loans of banks are under six-month moratorium. The risk of default looms large
How To Make FTAs Work
India’s experience with free trade agreements has been bitter. Can the country learn from its mistakes?
Food in a Tinderbox
The restaurant industry is close to irreparable damage. Can it be saved?
In a Tight Corner
States finally have headroom to borrow more from the market. But there’s a cost to it
New Gen Reliance
As Mukesh Ambani’s children play a greater role in Reliance Industries, the group is adding muscle to its digital, retail and petrochemicals businesses
Debt Funds: No Safety Tag
FROM THE NBFC LIQUIDITY CRISIS IN 2018 TO COLLAPSE OF SIX FRANKLIN TEMPLETON SCHEMES, DEBT FUNDS ARE NO LONGER CONSIDERED SAFE
MANAGING YOUR MONEY CAN BE TRICKY. SEND YOUR QUERIES, AND PERSONAL FINANCE EXPERTS WILL HELP YOU RESOLVE ANY ISSUE
INNOVATION SHOULD BE GIVEN A BOOST THROUGH TAX INCENTIVES”
In the middle of the current pandemic, India has emerged as a credible supplier of essential medicines. Four Indian pharma companies have just signed a partnership agreement with US-based Gilead for supply of its experimental coronavirus drug Remdesivir. Satish Reddy, President, Indian Pharmaceutical Alliance (which represents 24 leading pharma firms) and Chairman of Dr. Reddy’s Laboratories, speaks to Business Today’s Joe C. Mathew about how home-grown firms are serving India and the world during the Covid-19 crisis.
Education's Big Leap
Institutions of higher learning are graduating to new delivery models to engage with students online